dephostatin has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
dephostatin: from Streptomyces sp. MJ742-NF5; structure given in first source
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uesugi, Y | 1 |
| Fuse, I | 1 |
| Toba, K | 1 |
| Kishi, K | 1 |
| Hashimoto, S | 1 |
| Furukawa, T | 1 |
| Narita, M | 1 |
| Takahashi, M | 1 |
| Aizawa, Y | 1 |
1 other study available for dephostatin and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Inhibition of ATRA-induced myeloid differentiation in acute promyelocytic leukemia by a new protein tyrosine phosphatase inhibitor, 3,4-dephostatin.
Topics: Cell Differentiation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Granulocytes; Huma | 2000 |